S6E2: 2. The business and commercial considerations

The second podcast in our continuing series on drug development focuses on the commercial and business aspects of getting a growing company ready for a new drug. Today we talk with Gina Ford, Crinetics’ Vice president of Corporate Strategy and Commercial Planning, about the challenges and opportunities as these new potential medications move through the development pipeline.